Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. (Q34652744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

2 January 2020

main subject

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Kevin Whelan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

James O Lindsay

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the Nutrition Society

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

307-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

Double blind, placebo controlled trial of metronidazole in Crohn's disease

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

Role of the faecal stream in the maintenance of Crohn's colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

Effects of the faecal stream and stasis on the ileal pouch mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Lactobacillus GG in inducing and maintaining remission of Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Effects of probiotic on intestinal mucosa of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Mucosal flora in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Saccharomyces boulardii in maintenance treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria

1 reference

https://api.crossref.org/works/10.1017%2FS0029665107005563

7 January 2021

Anti-tuberculous therapy for maintaining remission of Crohn's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000299

Identifiers

DOI

10.1017/S0029665107005563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17637082%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference